Mnemo Therapeutics
Antonela Merlotti has a diverse work experience in the scientific field. Antonela began their career in 2010 as a PhD Student, Graduate Teaching Assistant, and MSc Student at the University of Buenos Aires. In 2015, they completed a Research Internship at the Institut Curie. From 2017 to 2022, they were a Postdoctoral Research Fellow at the Institut Curie. Antonela is currently a Senior Scientist at Mnemo Therapeutics.
Antonela Merlotti obtained their Doctor of Philosophy - PhD in Biological Chemistry & Immunology from the University of Buenos Aires in 2017, following their Master in Science Degree, Molecular Biology & Biotechnology, which they received from the same university in 2012.
Mnemo Therapeutics
1 followers
Mnemo Therapeutics is a biotechnology company focused on developing powerful cell therapies that create accessible cures for solid tumors and blood cancers. Its EnfiniT platform, a groundbreaking drug discovery engine, leverages a new class of antigens with greater tumor specificity and a suite of technologies to significantly improve T cell memory, persistence, and sensitivity. The result is dramatic improvement in the body’s immune response to overcome disease. Mnemo is built by a transatlantic team of scientists and biotech leaders united in their mission to create the most powerful immune therapies to deliver accessible cures for all patients in need.